Medical/Pharmaceuticals
Herbalgy 25th Anniversary - Touch Cool- Peppermint Cooling to Soothe Various Pains Anytime, Anywhere
HONG KONG, Sept. 30, 2024 /PRNewswire/ -- Since its establishment in 1999, Herbalgy Pharmaceutical Ltd. has been dedicated to developing products that meet the diverse needs ofHong Kong people. In addition to the "Herbalgy" brand, they have launched two other brands, "Touch Cool" and "Tibet Red,"...
2024-09-30 09:30
2293
Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) at 2024 CSCO Congress
CHENGDU, China, Sept. 29, 2024 /PRNewswire/ -- From September 25th to 29th, the 27th China Clinical Oncology Congress and the 2024 CSCO Annual Meeting were held inXiamen. Experts and scholars in the field of oncology from all over China gathered together to discuss the hotspots at the forefront o...
2024-09-29 11:52
3474
Frost & Sullivan Released Report: "2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends"
SHANGHAI, Sept. 28, 2024 /PRNewswire/ -- Frost & Sullivan released the "2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends" which focus on the progress of Chinese biopharmaceuticals going global and analyzes the driving forces behind their accelerated global expa...
2024-09-28 09:11
4173
TraceLink Propels Organizations Toward DSCSA Compliance Ahead of the November 2024 Deadline
BOSTON, Sept. 27, 2024 /PRNewswire/ -- With the Drug Supply Chain Security Act (DSCSA) stabilization period ending onNovember 27, 2024, the TraceLink customer and trading partner community of healthcare and life sciences companies continues to demonstrate market leadership in demonstrating compli...
2024-09-27 22:00
2483
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for ...
2024-09-27 19:00
2234
Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination Therapy in Colorectal Cancer
TAIPEI, Sept. 27, 2024 /PRNewswire/ -- Anbogen, a clinical-stage biotech company, today announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with BeiGene's anti-PD-1 antibody tislelizumab, in patients with mismatch repair–proficient (pMMR) or mi...
2024-09-27 16:00
2290
LiveWell Awarded Frost & Sullivan's 2024 Global Customer Value Leadership Award for Advancing Equitable and Accessible Mental Health Solutions
LiveWell's app integrates cutting-edge artificial intelligence (AI) and machine learning to provide personalized mental and behavioral health support, fostering user engagement across 27 countries and 9 languages. SAN ANTONIO, Sept. 27, 2024 /PRNewswire/ -- Frost & Sullivan recently researched t...
2024-09-27 02:00
3028
Hong Kong Breast Cancer Registry Report No. 16 Press Conference: Analyze De Novo Metastatic Breast Cancer, Precise Staging Enhances Treatment
HONG KONG, Sept. 26, 2024 /PRNewswire/ -- The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report today. The report aimed to shed light on the comparison between the patients of de novo metastatic breast cancer ...
2024-09-26 21:43
2692
ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.
The ZEISS MICOR 700 uses the ZEISS NULEX (non-ultrasonic lens extraction) procedure to help surgeons broaden their intraocular working space, minimizing risk to surrounding eye structures and increasing operating room efficiency. DUBLIN, Calif. and JENA, Germany, Sept. 26, 2024 /PRNewswire/ -- ZE...
2024-09-26 21:00
2342
ArkBio Announces Publication of Phase 3 Clinical Trial Results of Ziresovir for the Treatment of RSV Infection in The New England Journal of Medicine
SHANGHAI, Sept. 26, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of therapeutics in respiratory, infectious and pediatric diseases, announced that the results of the phase 3 clinical trial of zireso...
2024-09-26 20:28
3188
Innovent Announces NMPA Acceptance of NDA for Picankibart (Anti-IL-23p19 Antibody) for Treating Moderate to Severe Plaque Psoriasis
SAN FRANCISCO and SUZHOU, China, Sept. 26, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...
2024-09-26 12:15
3405
ISUOG 2024 | Redefining Women's Health with SonoScape's New Fenix 80 Series
BUDAPEST, Hungary, Sept. 26, 2024 /PRNewswire/ -- SonoScape
2024-09-26 12:02
2769
Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study Findings
PERTH, Australia, Sept. 26, 2024 /PRNewswire/ -- A groundbreaking study
published inClinical Obesity reveals that providing personalised energy
expenditure data significantly improves weight loss outcomes in individuals
with obesity1
2024-09-26 08:11
2380
Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis
SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewedstudy validating its innovative method for measuring central aortic pressure...
2024-09-26 07:15
2117
Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care
The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules SALT LAKE CITY and NASHVILLE, Tenn., Sept. 25, 2024 /PRNewswir...
2024-09-25 22:02
2822
Shin-Etsu SE Tylose and LBB Specialties Announce Distribution Partnership for Cellulose Pharma Excipients in North and Central America
NORWALK, Conn., Sept. 25, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution inNorth America, announces a new partnership with SE TyloseUSA for cellulose excipients in the Pharma Excipients and Nutra Ingredients markets. EffectiveNovember 1, 2...
2024-09-25 22:00
1999
Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC Regulatory Harmonization Steering Committee
PHILADELPHIA, Sept. 25, 2024 /PRNewswire/ -- Rx-360® is pleased to announce that it has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global Medical Product Supply Chain Integrity Priority Work Area R...
2024-09-25 21:09
2748
CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean - Decentralised Approach Serves the Needs of the Caribbean Community
HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ -- CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed's Xceler8 Platform across theCaribbean. Implementing this cutting-edge technology in the region marks a major advancement in the field ofCaribbean ge...
2024-09-25 19:00
2361
New Research from the International Coaching Federation Highlights Trends in Workplace Burnout
- Demand for mental well-being support becoming widespread - LEXINGTON, Ky., Sept. 25, 2024 /PRNewswire/ -- New research, released today by the International Coaching Federation (ICF), indicates growing workplace demand for mental well-being support. With mental well health concerns including b...
2024-09-25 17:00
2552
GSK's Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia
* Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV * Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy observed in adults with co-morbidities vii KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire...
2024-09-25 16:45
2905
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 326 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 301 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09